Theranostic 203/212Pb-labeled octreotate analogs (AlphaMedix TM) and their preclinical characterization for the Phase I clinical studies in neuroendocrine cancer patients
Title:
Theranostic 203/212Pb-labeled octreotate analogs (AlphaMedix TM) and their preclinical characterization for the Phase I clinical studies in neuroendocrine cancer patients
Author:
Tworowska, I. Stallons, T. Delpassand, E. Torgue, J. Saidi, A. Jurek, P. Kiefer, G. Rojas-Quijano, F. Ghaly, M. Frey, E. Sgouros, G.